Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

NCT01205022 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Colon Cancer
Recurrent Rectal Cancer
Stage IV Colon Cancer
Stage IV Rectal Cancer

Interventions

DRUG: irinotecan hydrochloride
DRUG: leucovorin calcium
DRUG: fluorouracil
BIOLOGICAL: bevacizumab
RADIATION: yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A
OTHER: laboratory biomarker analysis

Sponsor

City of Hope Medical Center

Collaborators

[object Object]